Detailed price information for Ntg Clarity Networks Inc (NYWKF) from The Globe and Mail including charting and trades.
1d
PDS Biotech outlines VERSATILE-003 amendment targeting interim PFS with approximately 250 patients
Dr. Kirk Shepard (Chief Medical Officer) detailed a pivotal change to the Phase III VERSATILE-003 study design: “we adopted an amendment to our VERSATILE-003 trial, revising the design to incorporate ...
In first line, iadademstat with azacitidine and venetoclax continues to show favorable safety and 100% ORR, with a composite complete remission ...
Investor Webcast Scheduled for 8:00 am ETPRINCETON, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS ...
At just 19 years old, the first-year student was the only undergraduate selected to present research at a workshop hosted by ...
During these uncertain times, our strategy is to stay anchored to what we control - disciplined capital allocation, safe and ...
The National Cancer Institute of the NIH organized the workshop, which featured poster presentations from researchers ...
In this episode, Tom Fox welcomes Edye Edens about launching her Life Sciences Law Group (“Eedee Law”) after years of contracting in life ...
National Cancer Institute Director Anthony Letai, M.D., Ph.D., has attempted to fight back against the “misinformation” surrounding a perceived fall in federal cancer research budgets, insisting that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results